Canton Strategic Holdings (CNTN) Notes Payables (2020 - 2025)
Canton Strategic Holdings posted quarterly Notes Payables of $161117.0 for Q3 2025, down 35.48% on a QoQ basis from $249716.0 in Q2 2025.
Canton Strategic Holdings (CNTN) has 3 years of Notes Payables data on file, last reported at $161117.0 in Q3 2025.
- For the quarter ending Q3 2025, Notes Payables changed N/A year-over-year to $161117.0; the trailing twelve-month figure through Sep 2025 stood at $161117.0 (changed N/A YoY), and the FY2021 full-year result was $1.4 million, up 147.16% from the prior year.
- Notes Payables for Q3 2025 stood at $161117.0, down from $249716.0 in the prior quarter.
- Across five years, Notes Payables topped out at $1.4 million in Q4 2021 and bottomed at $161117.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 161,117.00 |
| Jun 30, 2025 | 249,716.00 |
| Mar 31, 2025 | 271,454.00 |
| Dec 31, 2021 | 1.39 Mn |
| Dec 31, 2020 | 563,425.00 |